CAMBRIDGE, Mass., April 20, 2016 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. INFI will host a conference call on Wednesday, May 4, 2016, at 4:30 p.m. ET. During the call, management will review the company's first quarter 2016 financial results and provide an update on Infinity's business.
A live webcast of the conference call can be accessed in the Investors/Media section of Infinity's website at www.infi.com. To participate in the conference call, please dial 1-877-316-5293 (domestic) and 1-631-291-4526 (international) five minutes prior to start time. The conference ID number is 89736154. An archived version of the webcast will be available on Infinity's website for 30 days.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative biopharmaceutical company dedicated to discovering, developing and delivering best-in-class medicines to people with difficult-to-treat diseases. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. For more information on Infinity, please refer to the company's website at www.infi.com.
Contact:
Christi Waarich
Senior Manager, Investor Relations
617-453-1363 or Christi.Waarich@infi.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/infinity-announces-the-date-of-its-first-quarter-2016-financial-results-conference-call-and-webcast-300254013.html
SOURCE Infinity Pharmaceuticals, Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.